Desvenlafaxine Tablet, Extended Release
Product Images NDC 70436-013
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine (NDC 70436-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Figure 1)
Figure 2 (Figure 2)
Figure 3 (Figure 3)
Figure-4 (Figure 4)
Figure-5 (Figure 5)
50 mg, 30 Ct (50mg 30ct Coo India)
50 mg, 30 Ct (50mg 30ct Coo Malta)
50 mg, 90 Ct (50mg 90ct Coo India)
50 mg, 90 Ct (50mg 90ct Coo Malta)
100 mg, 30 Ct (100mg 30ct Coo India)
100 mg, 30 Ct (100mg 30ct Coo Malta)
100 mg, 90 Ct (100mg 90ct Coo India)
100 mg, 90 Ct (100mg 90ct Coo Malta)
25 mg, 30 Ct (25mg 30ct Coo India)
25 mg, 30 Ct (25mg 30ct Coo Malta)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.